Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 494 publications
A comparison of the persistence of acute treatment with rimegepant versus oral triptans in patients with migraine: A retrospective analysis of US claims data.
Journal: Cephalalgia : an international journal of headache
Published: July 28, 2025
A Pharmacovigilance Study from 2004 to 2024 Utilizing the FDA Adverse Event Reporting System (FAERS) Examines Ischemic Adverse Events Linked to Triptan Use in Migraine Therapy.
Journal: Journal of pain research
Published: July 04, 2025
Meloxicam and Rizatriptan Benzoate.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: June 25, 2025
Rizatriptan vs Placebo for Attacks of Vestibular Migraine: A Randomized Clinical Trial.
Journal: JAMA neurology
Published: May 12, 2025
Neuroinflammatory crosstalk in migraine: consolidated activity of rizatriptan and meloxicam in suppressing CGRP-induced nociception and COX-mediated inflammation.
Journal: Inflammopharmacology
Published: May 07, 2025
A fixed-dose combination of meloxicam and rizatriptan (Symbravo) for migraine.
Journal: The Medical letter on drugs and therapeutics
Published: April 22, 2025
Induction of more severe central sensitization in a medication overuse headache model mice through active ingestion of rizatriptan.
Journal: The journal of headache and pain
Published: March 13, 2025
Evaluating Triptan Safety in Pediatric Migraine Management: A Comprehensive Pharmacovigilance Analysis.
Journal: Journal of pain research
Published: March 06, 2025
Pediatric Triptan-induced Reversible Cerebral Vasoconstriction Syndrome with Both Hemorrhagic and Ischemic Stroke: Case Report and Literature Review.
Journal: NMC case report journal
Published: February 06, 2025
Transient global amnesia predisposed by rizatriptan and temazepam.
Journal: BMJ case reports
Published: November 28, 2024
The impact of headache specialist density and the introduction of gepants and lasmitidan on prescriptions for acute migraine treatments: a regression and interrupted time series analysis.
Journal: Frontiers in neurology
Published: November 19, 2024
Last Updated: 10/31/2025